These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 18759767)
1. A multicentre randomised clinical endpoint study of PARMA 5 computer-assisted oral anticoagulant dosage. Poller L; Keown M; Ibrahim S; Lowe G; Moia M; Turpie AG; Roberts C; van den Besselaar AM; van der Meer FJ; Tripodi A; Palareti G; Jespersen J Br J Haematol; 2008 Oct; 143(2):274-83. PubMed ID: 18759767 [TBL] [Abstract][Full Text] [Related]
2. A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program. Poller L; Keown M; Ibrahim S; Lowe G; Moia M; Turpie AG; Roberts C; van den Besselaar AM; van der Meer FJ; Tripodi A; Palareti G; Shiach C; Bryan S; Samama M; Burgess-Wilson M; Heagerty A; Maccallum P; Wright D; Jespersen J; Thromb Haemost; 2009 Mar; 101(3):487-94. PubMed ID: 19277410 [TBL] [Abstract][Full Text] [Related]
3. An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage. Poller L; Keown M; Ibrahim S; Lowe G; Moia M; Turpie AG; Roberts C; van den Besselaar AM; van der Meer FJ; Tripodi A; Palareti G; Shiach C; Bryan S; Samama M; Burgess-Wilson M; Heagerty A; Maccallum P; Wright D; Jespersen J J Thromb Haemost; 2008 Jun; 6(6):935-43. PubMed ID: 18489430 [TBL] [Abstract][Full Text] [Related]
4. "Zeus" a new oral anticoagulant therapy dosing algorithm: a cohort study. Cafolla A; Melizzi R; Baldacci E; Pignoloni P; Dragoni F; Campanelli M; Caraccini R; Foà R Thromb Res; 2011 Oct; 128(4):325-30. PubMed ID: 21600633 [TBL] [Abstract][Full Text] [Related]
5. Warfarin anticoagulation intensity in specialist-based and in computer-assisted dosing practice. Onundarson PT; Einarsdottir KA; Gudmundsdottir BR Int J Lab Hematol; 2008 Oct; 30(5):382-9. PubMed ID: 19046313 [TBL] [Abstract][Full Text] [Related]
6. A computerized regulation of dosage in oral anticoagulant therapy. Mariani G; Manotti C; Dettori AG Ric Clin Lab; 1990; 20(2):119-25. PubMed ID: 2371492 [TBL] [Abstract][Full Text] [Related]
7. A computer generated induction system for hospitalized patients starting on oral anticoagulant therapy. Ageno W; Johnson J; Nowacki B; Turpie AG Thromb Haemost; 2000 Jun; 83(6):849-52. PubMed ID: 10896237 [TBL] [Abstract][Full Text] [Related]
8. Low rate of bleeding and thrombotic complications of oral anticoagulant therapy independent of age in the real-practice of an anticoagulation clinic. Poli D; Antonucci E; Lombardi A; Boddi V; Gensini GF; Abbate R; Prisco D Blood Coagul Fibrinolysis; 2003 Apr; 14(3):269-75. PubMed ID: 12695750 [TBL] [Abstract][Full Text] [Related]
9. Subtherapeutic oral anticoagulant therapy: frequency and risk factors. Rombouts EK; Rosendaal FR; van der Meer FJ Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419 [TBL] [Abstract][Full Text] [Related]
10. A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing. Gardiner C; Williams K; Longair I; Mackie IJ; Machin SJ; Cohen H Br J Haematol; 2006 Mar; 132(5):598-603. PubMed ID: 16445833 [TBL] [Abstract][Full Text] [Related]
11. Computer-aided dosage in oral anticoagulation therapy using phenprocoumon. Problems and approaches. Cromme L; Völler H; Gäbler F; Salzwedel A; Taborski U Hamostaseologie; 2010 Nov; 30(4):183-9. PubMed ID: 21057712 [TBL] [Abstract][Full Text] [Related]
12. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon. van Leeuwen Y; Rosendaal FR; van der Meer FJ Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321 [TBL] [Abstract][Full Text] [Related]
13. Coordinated anticoagulation management in a rural setting. Hodge K; Janus E; Sundararajan V; Taylor S; Brand W; Ibrahim JE; Wolff A Aust Fam Physician; 2008 Apr; 37(4):280-3. PubMed ID: 18398530 [TBL] [Abstract][Full Text] [Related]
14. The Belgian Improvement Study on Oral Anticoagulation Therapy: a randomized clinical trial. Claes N; Buntinx F; Vijgen J; Arnout J; Vermylen J; Fieuws S; Van Loon H Eur Heart J; 2005 Oct; 26(20):2159-65. PubMed ID: 15917280 [TBL] [Abstract][Full Text] [Related]
15. Does the Birmingham model of oral anticoagulation management in primary care work outside trial conditions? Fitzmaurice DA; Murray ET; Gee KM; Allan TF Br J Gen Pract; 2001 Oct; 51(471):828-9. PubMed ID: 11677707 [TBL] [Abstract][Full Text] [Related]
16. A prospective controlled study of a computer-assisted acenocoumarol dosage program. Marco F; Sedano C; Bermúdez A; López-Duarte M; Fernández-Fontecha E; Zubizarreta A Pathophysiol Haemost Thromb; 2003; 33(2):59-63. PubMed ID: 14624045 [TBL] [Abstract][Full Text] [Related]
18. Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Siebenhofer A; Rakovac I; Kleespies C; Piso B; Didjurgeit U Thromb Haemost; 2007 Mar; 97(3):408-16. PubMed ID: 17334508 [TBL] [Abstract][Full Text] [Related]
19. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95). Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081 [TBL] [Abstract][Full Text] [Related]
20. Patients who take uneven doses of acenocoumarol exhibit significant fluctuating levels of anticoagulation. Marco F; Gutiérrez JI; Orkolaga K; Márquez JA; Ojínaga MJ; de Zárate IO; de Heredia JM Blood Coagul Fibrinolysis; 2006 Sep; 17(6):509-12. PubMed ID: 16905959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]